medroxyprogesterone acetate has been researched along with Proteinuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irish, A; Kong, WY; Leedman, P | 1 |
| Alpers, CE; Clark, EA; Elkon, KB; Hudkins, KL; Hughes, GC; Martin, D; Zhang, K | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Proteinuria
| Article | Year |
|---|---|
A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria.
Topics: Antineoplastic Agents, Hormonal; Cushing Syndrome; Female; Humans; Hypertension; Iatrogenic Disease; Medroxyprogesterone Acetate; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Proteinuria; Treatment Outcome | 2014 |
Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Topics: Animals; Autoantibodies; B7-2 Antigen; Complement C3; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Progesterone; Proteinuria; Th1 Cells | 2009 |